Five Prime Therapeutics Inc. appointed Bryan Irving as executive vice president and chief scientific officer.
Irving joined the South San Francisco, Calif.-based clinical-stage biotechnology company in August 2017 as vice president of research.
Five Prime Therapeutics names chief scientific officer
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Five Prime Therapeutics Inc. appointed Bryan Irving as executive vice president and chief scientific officer.
Irving joined the South San Francisco, Calif.-based clinical-stage biotechnology company in August 2017 as vice president of research.